Literature DB >> 15841414

Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders.

Jiro Fukae1, Masashi Takanashi, Shin-ichiro Kubo, Ken-ichi Nishioka, Yusaku Nakabeppu, Hideo Mori, Yoshikuni Mizuno, Nobutaka Hattori.   

Abstract

Oxidative stress including DNA oxidation is implicated in Parkinson's disease (PD). We postulated that DNA repair enzymes such as 8-oxoguanosine DNA glycosylase (OGG1) are involved in the PD process. We performed immunohistochemical and biochemical studies on brains of patients with PD and those of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) as disease controls, and control subjects. We found higher expression levels of mitochondrial isoforms of OGG1 enzymes in the substantia nigra (SN) in cases of PD. Furthermore, Western blot analysis revealed high OGG1 levels in the SN of the patients with PD. Our results indicate the importance of oxidative stress within the susceptible lesions in the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15841414     DOI: 10.1007/s00401-004-0937-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

Review 1.  Regulation of DNA glycosylases and their role in limiting disease.

Authors:  Harini Sampath; Amanda K McCullough; R Stephen Lloyd
Journal:  Free Radic Res       Date:  2012-02-06

2.  8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair.

Authors:  Zijing Sheng; Sugako Oka; Daisuke Tsuchimoto; Nona Abolhassani; Hiroko Nomaru; Kunihiko Sakumi; Hidetaka Yamada; Yusaku Nakabeppu
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

3.  Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Authors:  Laurie H Sanders; Jennifer McCoy; Xiaoping Hu; Pier G Mastroberardino; Bryan C Dickinson; Christopher J Chang; Charleen T Chu; Bennett Van Houten; J T Greenamyre
Journal:  Neurobiol Dis       Date:  2014-06-27       Impact factor: 5.996

Review 4.  DNA repair deficiency in neurodegeneration.

Authors:  Dennis Kjølhede Jeppesen; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

5.  Editor's Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson's Disease Risk.

Authors:  Laurie H Sanders; Kimberly C Paul; Evan H Howlett; Hakeem Lawal; Sridhar Boppana; Jeff M Bronstein; Beate Ritz; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

Review 6.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

7.  Broad DNA repair responses in neural injury are associated with activation of the IL-6 pathway in cholesterol-fed rabbits.

Authors:  Min Wu; Aaron Audet; Jenna Cusic; Drew Seeger; Richard Cochran; Othman Ghribi
Journal:  J Neurochem       Date:  2009-09-18       Impact factor: 5.372

8.  Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms.

Authors:  Tommaso Cornetta; Clarice Patrono; Irene Terrenato; Francesca De Nigris; Anna Rita Bentivoglio; Antonella Testa; Valentina Palma; Tommaso Poggioli; Luca Padua; Renata Cozzi
Journal:  Cell Mol Neurobiol       Date:  2013-04-04       Impact factor: 5.046

Review 9.  Mitochondrial DNA damage and repair in neurodegenerative disorders.

Authors:  Jenq-Lin Yang; Lior Weissman; Vilhelm A Bohr; Mark P Mattson
Journal:  DNA Repair (Amst)       Date:  2008-05-07

10.  Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.

Authors:  Charles R Arthur; Stephanie L Morton; Lisa D Dunham; Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2009-09-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.